Theravance Biopharma(TBPH)
搜索文档
Theravance Biopharma(TBPH) - 2023 Q1 - Earnings Call Presentation
2023-05-09 14:37
| --- | --- | |---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------| | | | | | | | | | | | | | First Quarter 2023 Financial Results and Business Update | | | May 8, 2023 | | | THERAVANCE BIOPHARMA ® ...
Theravance Biopharma(TBPH) - 2023 Q1 - Earnings Call Transcript
2023-05-09 10:39
Theravance Biopharma, Inc. (NASDAQ:TBPH) Q1 2023 Earnings Conference Call May 8, 2023 5:00 PM ET Company Participants Rick Winningham - Chief Executive Officer Rhonda Farnum - Chief Business Officer Rick Graham - Senior Vice President of Research and Development Aziz Sawaf - Chief Financial Officer Conference Call Participants David Risinger - SVB Securities Jingming Chen - Evercore Divya Rao - TD Cowen Operator Ladies and gentlemen, good afternoon. I’d like to welcome everyone to the Theravance Biopharma F ...
Theravance Biopharma(TBPH) - 2022 Q4 - Earnings Call Presentation
2023-03-09 03:09
| --- | --- | |-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------| | | | | | | | | | | | | | Strategic Actions and Fourth Quarter / Full Year 2022 Financial Results and Business Update February 2 ...
Theravance Biopharma(TBPH) - 2022 Q4 - Annual Report
2023-03-02 05:39
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-36033 THERAVANCE BIOPHARMA, INC. (Exact name of registrant as specified in its charter) Cayman Islands 98-1226628 (Sta ...
Theravance Biopharma(TBPH) - 2022 Q4 - Earnings Call Transcript
2023-02-28 10:25
Theravance Biopharma Inc. (NASDAQ:TBPH) Q4 2022 Results Conference Call February 27, 2023 5:00 PM ET Company Participants Rick Winningham - Chairman and Chief Executive Officer Rhonda Farnum - Senior Vice President, Chief Business Officer Rick Graham - Senior Vice President, Research and Development Aziz Sawaf - Chief Financial Officer Conference Call Participants David Risinger - SVB Securities Douglas Tsao - H.C. Wainwright Eva Privitera - Cowen Vikram Purohit - Morgan Stanley Liisa Bayko - Evercore ISI O ...
Theravance Biopharma(TBPH) - 2022 Q3 - Earnings Call Presentation
2022-11-08 12:41
| --- | --- | |---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------| | | | | | | | | | | | | | Third Quarter 2022 Financial Results and Business Update | | | November 7, 2022 | | | THERAVANCE BIOPHAR ...
Theravance Biopharma (TBPH) Investor Presentation - Slideshow
2022-09-17 06:13
| --- | --- | |---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------| | | | | | | | | | | | | | Transformed and Focused on Medicines that Make a Difference | | | September 13, 2022 | | | THERAVANCE BI ...
Theravance Biopharma(TBPH) - 2022 Q2 - Earnings Call Presentation
2022-08-06 06:09
| --- | --- | --- | |--------------------------------------------------------------------------------------------------------------------|-------|-------| | | | | | | | | | | | | | | | | | | | | | Second Quarter 2022 | | | | Financial Results and Business Update | | | | August 4, 2022 THERAVANCE BIOPHARMA®, THERAVANCE®, the Cross/Star logo and MEDICINES THAT MAKE A DIFFERENCE® are | | | registered trademarks of the Theravance Biopharma group of companies (in the U.S. and certain other countries). All third ...
Theravance Biopharma(TBPH) - 2022 Q1 - Earnings Call Presentation
2022-05-07 04:02
| --- | --- | |----------------------------------------------------------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | First Quarter 2022 Financial Results and Business Update | | | May 5, 2022 | | THERAVANCE BIOPHARMA®, THERAVANCE®, the Cross/Star logo and MEDICINES THAT MAKE A DIFFERENCE® are registered trademarks of the Theravance Biopharma group of companies (in the U.S. and certain other countries). All third party trademarks used herein are the property of their respective owners. © 2022 ...
Theravance Biopharma(TBPH) - 2021 Q4 - Earnings Call Presentation
2022-02-25 00:20
| --- | --- | |-------------------------------------------------------------------------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Fourth Quarter and Full Year 2021 Financial Results and Business Update | | | February 23, 2022 | | THERAVANCE BIOPHARMA®, THERAVANCE®, the Cross/Star logo and MEDICINES THAT MAKE A DIFFERENCE® are registered trademarks of the Theravance Biopharma group of companies (in the U.S. and certain other countries). All third party trademarks used herein are ...